Financials

  • Market Capitalization 90.64 M
  • Employee 10
  • Founded 2012
  • CEO N/A
  • Website www.atarabio.com
  • Headquarter Delaware, United States
  • FIGI BBG005Q3MQY4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
7.04
Rapporto prezzo/fatturato
1.9

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3980
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.51 USD-1.95%-1.95%-4.43%-74.23%91.09 M USD
3982
ICCC
ImmuCell Corporation - Common Stock
10.00 USD-0.20%-0.89%-10.71%+58.98%90.82 M USD
3997
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.07 USD-3.72%-5.91%+38.00%+55.64%88.71 M USD
3998
RLYB
Rallybio Corporation - Common Stock
16.70 USD-0.36%+0.60%+3.09%+2992.59%88.69 M USD

Notizie